0001628280-26-009842
SEC filingBunge Global S.A. reported net sales of $70.33 billion for fiscal year 2025, generating gross profit of $3.41 billion. The company achieved net income attributable to Bunge shareholders of $816 million, with basic and diluted earnings per share of $5.00. Cash provided by operating activities was $844 million, while cash used for investing activities was $5.23 billion primarily due to $4.20 billion in business acquisitions and $1.72 billion in capital expenditures. The company ended the year with total assets of $44.53 billion and total equity of $17.37 billion, including $15.90 billion in Bunge shareholders' equity. The balance sheet shows $13.20 billion in inventories and total debt of $14.05 billion (short-term $3.88 billion, current portion of long-term $1.34 billion, and long-term $8.83 billion).
Bunge Global S.A. reported fiscal year 2025 results with net sales of $70.33 billion and cost of goods sold of $66.92 billion, resulting in gross profit of $3.41 billion. The company generated income from continuing operations before income tax of $1.13 billion, with income tax expense of $288 million leading to income from continuing operations of $846 million. After accounting for a $3 million loss from discontinued operations and $27 million attributable to noncontrolling interests, net income attributable to Bunge shareholders was $816 million. Basic and diluted earnings per share were both $5.00. The company's selling, general and administrative expenses totaled $2.11 billion, while interest expense was $628 million partially offset by $202 million in interest income.
The filing provides consolidated financial data without segment breakdowns. Net sales of $70.33 billion represent the company's total revenue from operations. The document does not disclose segment-level revenue, geographic mix, or specific growth drivers beyond the consolidated figures. All revenue-related information is presented at the consolidated level without further disaggregation in the provided data.
Gross profit margin can be calculated from the provided figures as 4.85% ($3.41 billion gross profit divided by $70.33 billion net sales). Operating income is not explicitly stated in the XBRL data, but income from continuing operations before income tax was $1.13 billion. The company incurred $2.11 billion in selling, general and administrative expenses, which represents approximately 3.0% of net sales. Other income items included $289 million in other income net, $26 million in income from affiliates, and a $51 million foreign exchange loss.
Cash provided by operating activities was $844 million, driven by net income of $843 million adjusted for non-cash items including $703 million in depreciation, depletion and amortization. Cash used for investing activities was $5.23 billion, primarily from $4.20 billion in business acquisitions and $1.72 billion in capital expenditures. Cash provided by financing activities was $2.23 billion, with $3.60 billion in proceeds from long-term debt and $2.10 billion from short-term debt. The balance sheet shows total assets of $44.53 billion including $24.39 billion in current assets ($13.20 billion inventories, $3.87 billion trade receivables). Total liabilities were $27.10 billion including $14.05 billion in total debt. Equity stood at $17.37 billion with $15.90 billion attributable to Bunge shareholders.
The provided document content does not include management guidance, strategic priorities, or specific risk factors beyond the financial statements. The filing presents historical financial data for fiscal year 2025 without forward-looking statements or outlook information in the extracted content. No management discussion and analysis section is included in the provided document text.